Answers are grounded in this paper and cite their sources.
Patient-derived stem cell-based neuronal models hold great promise for advancing research into monogenic neurodevelopmental disorders (mNDDs). These neuronal models are generated using induced pluripotent stem cell (iPSC) technologies, and are perceived as “ethically sensitive”. To date, ethical discussions on the use of neuronal models have predominantly focused on three-dimensional (3D) neuronal models, such as brain organoids, while two-dimensional (2D) neuronal models - which are widely used in current research settings - remain underexplored. A better understanding of the perspectives of parents of children with mNDDs on ethical issues - including the moral status of 2D models, informed consent, autonomy, privacy and misuse - is needed. We report the results of a semi-structured interview study among parents of children with mNDDs ( n = 28) investigating their perspectives on the ethically responsible use of 2D patient-derived neuronal models in research. Respondents ascribed limited intrinsic value to neuronal models, often viewing them as ethically comparable to other somatic cells. They were highly motivated to enroll their child in iPSC research, but suggested that researchers: (1) restrict the use of their child’s donated material to purposes benefiting the mNDD community, (2) protect their child’s privacy, (3) communicate about research findings and reuse of donated material, and (4) minimize risks and burdens of research procedures for their (vulnerable) child. Based on these findings, we provide recommendations to research groups for informed consent and engagement processes to support responsible inclusion of children with mNDDs and their families in research using iPSC-based neuronal models.
No takes yet. Share an insight, caveat, or question.
Till et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: